Bellevue
Healthcare Trust plc
(the
"Company")
Board
Appointments and Succession Planning
Following a comprehensive selection
process, conducted using an independent third-party search firm,
the Company is pleased to announce the appointment of two
independent non-executive directors to the Board. Clare Brady and
Sarah MacAulay will join the Board with immediate
effect.
Clare is a chartered governance
professional with 35 years' experience in banking and financial
services. Clare is Chairman of Fidelity Asian Values plc and a
non-executive director of The Golden Charter Trust Limited.
She is also non-executive director, Audit Committee Chairman
and member of the Risk Committee and Conflicts Committee of M&G
Group Limited, M&G Investment Management Limited and M&G
Alternatives Investment Management Limited. Clare was a
non-executive director of Credit Suisse until its merger with UBS.
In her executive career, she was a Director of the International
Monetary Fund ("IMF") and prior to that, the Auditor General at the
World Bank, based in Washington D.C. Previously, Clare headed audit
and compliance functions at the Bank of England, Barclays Capital,
HSBC and Deutsche Bank.
Sarah has over twenty years of fund
management experience based in both London and Hong Kong, managing
unit trusts and institutional assets. She is currently Chairman of
Schroder Asian Total Return Investment Company plc and a
non-executive director of Fidelity Japan Trust plc and Baillie
Gifford China Growth Trust plc. Sarah was formerly a Director of
Baring Asset Management (Asia) Ltd in Hong Kong, Asian Investment
Manager at Kleinwort Benson Investment Management and Eagle Star in
London.
The Appointment of Clare Brady and
Sarah MacAulay falls to be ratified by shareholders at the Annual
General Meeting ("AGM") of the Company to be held in April
2025.
Randeep Grewal, Chairman,
commented:
"We are delighted to welcome both Clare and Sarah to the
Board. They bring a wealth of oversight and board experience
besides familiarity with investment markets. We are confident that
they will both make a valuable contribution to the
Company."
Randeep Grewal and Paul Southgate,
who have served on the Board since the launch of the Company in
December 2016, will retire from the Board at the April 2025 AGM.
Kate Bolsover, who joined the Board in July 2021, will become
Chairman following Randeep Grewal's retirement. Clare Brady will
assume the role of Chairman of the Audit Committee at the April
2025 AGM, with Jo Dixon remaining on the Board as Senior
Independent Director until the 2026 AGM.
The Board is engaged in an ongoing
search with a head-hunter for another suitable independent
non-executive director to further strengthen the Board. In addition
to Clare Brady and Sarah MacAulay's appointments, the Board expects
to appoint a further non-executive director to succeed Jo Dixon
upon her retirement at the AGM in 2026. The Board is cognisant that
they need to appoint a Parker Review compliant individual and will
provide further updates in due course.
There is no information to be
disclosed in respect of UKLR 6.4.8 for Ms Brady or Ms MacAulay and
as at the date of this announcement, they have no beneficial
interests in the ordinary shares of the Company.
LEI: 213800HQ3J3H9YF2UI82
Enquiries:
NSM Funds (UK) Limited
Company Secretary
bellevue@nsm.group
